Takeda has joined the European project SEARCH (Synthetic Healthcare Data Governance Hub), contributing its clinical and scientific expertise to support the development of a responsible and collaborative ecosystem for synthetic health data and artificial intelligence in healthcare.

SEARCH, funded by the Innovative Health Initiative (IHI JU), brings together 26 organizations from 14 countries to address key challenges in data-driven healthcare. Coordinated by Trinity College Dublin through the Trinity Translational Medicine Institute (TTMI), the project focuses on enabling the generation, validation and ethical use of synthetic data to support more personalised, secure and equitable healthcare systems.

Takeda’s involvement in SEARCH reflects its commitment to advancing open science and contributing to the responsible use of health data. The company brings experience in clinical research, data quality and regulatory alignment, particularly in therapeutic areas such as oncology, rare diseases and inflammatory conditions. Its contribution also supports the development of validation methodologies and governance frameworks that promote transparency, trust and compliance with European standards.

Synthetic data offers a promising alternative to real clinical datasets, which are often difficult to access due to privacy concerns and legal restrictions. SEARCH proposes a model in which synthetic datasets replicate the statistical properties of real data without exposing patient identities. These datasets will be used to train advanced AI models that support diagnosis, prediction and treatment, while safeguarding individual privacy.

Takeda also supports the development of federated platforms and learning algorithms that enable collaboration between institutions without the need to share sensitive data. This approach facilitates scalable research while maintaining data protection and ethical integrity.

The project aims to deliver clinical use cases that demonstrate the real-world impact of synthetic data and AI in complex disease areas. These include simulated clinical trials, interoperable data infrastructures and open-source tools that can be adopted by researchers, healthcare providers and developers across Europe.

Details of Takeda’s participation in SEARCH have been published on the company’s corporate website, highlighting the strategic relevance of synthetic data and responsible AI in the future of healthcare.

SEARCH will run until September 2028. By the end of the project, the consortium expects to deliver a fully operational ecosystem for FAIR (Findable, Accessible, Interoperable and Reusable) synthetic data, along with ethical and regulatory recommendations to guide future applications.

Takeda is pleased to collaborate with leading institutions across Europe in this initiative, contributing to a shared vision of data-driven healthcare that is innovative, inclusive and grounded in ethical practice.